Ligand Pharmaceuticals reported $12.36M in Cost of Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Acorda Therapeutics ACOR:US $ 8.8M 2.83M
Agenus AGEN:US $ 2.02M 1.48M
Amgen AMGN:US $ 1510M 51M
Anika Therapeutics ANIK:US $ 14.8M 0.09M
Baxter International BAX:US $ 2289M 68M
Bristol Myers Squibb BMY:US $ 2677M 206M
Clovis Oncology CLVS:US $ 9.22M 0.2M
Eli Lilly And LLY:US $ 1430.5M 641.6M
Endo International Ordinary Shares ENDP:US $ 263.79M 84.03M
Gilead Sciences GILD:US $ 1442M 18M
GlaxoSmithKline GSK:LN 213600M 55400M
Glaxosmithkline GSK:US $ 2136M 1509M
Harsco HSC:US $ 403.2M 26.18M
Heron Therapeutics HRTX:US $ 16.18M 4.82M
Insmed INSM:US $ 16.4M 4.2M
Intrexon XON:US $ 1.81M 15.29M
Karyopharm Therapeutics KPTI:US $ 939K 487K
Lannett LCI:US $ 66.33M 8.95M
Ligand Pharmaceuticals LGND:US $ 12.36M 7.66M
MacroGenics MGNX:US 2.4M 2.35M
Merk MRK:US $ 3698M 1636M
Pacira Pharmaceuticals PCRX:US $ 50.63M 14.55M
Pfizer PFE:US $ 8671M 1339M
Rigel Pharmaceuticals RIGL:US $ 1.04M 0.92M
Teva Pharmaceutical Industries TEVA:US $ 1958M 99M
Veracyte VCYT:US $ 25.03M 1.32M